Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Reese Pharmaceutical Company
FDA Inspection
•Reese Pharmaceutical Company•January 11, 2012

Reese Pharmaceutical Company – FDA Inspection, Jan 11, 2012

Record Details

This FDA Inspection record concerns Reese Pharmaceutical Company, with an inspection on January 11, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Reese Pharmaceutical Company
Inspection Date
January 11, 2012
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · 9ae2572f-7f09-4e34-9024-c535e3b62235

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
758639
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

5
  1. 21 CFR 211.188(b)(6)Inspection of packaging and labeling area
  2. 21 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.
  3. 21 CFR 211.125(a)Strict control not exercised over labeling issued
  4. 21 CFR 211.180(e)(1)Review of representative number of batches
  5. 21 CFR 211.100(b)SOPs not followed / documented

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Reese Pharmaceutical Company

7
DateClassificationOfficeProject area
September 25, 2025Not classifiedCincinnati District Office
December 9, 2021NAICenter for Food Safety and Applied NutritionFood Composition, Standards, Labeling and Econ
December 8, 2021NAICenter for Food Safety and Applied NutritionFood Composition, Standards, Labeling and Econ
June 5, 2017NAICenter for Food Safety and Applied NutritionPesticides and Chemical Contaminants
April 25, 2017NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 7 other inspections on the company page
Other documents for Reese Pharmaceutical Company
  • FDA Inspection 1287906 - 2025-09-25
  • FDA Inspection 1160702 - 2021-12-09
  • FDA Inspection 1160701 - 2021-12-08
  • FDA Inspection 1017672 - 2017-06-05
  • FDA Inspection 1012578 - 2017-04-25

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Reese Pharmaceutical Company
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.